title: Functional assessment of a skin care system in patients on chemotherapy.
abstract: OBJECTIVE
  Cancer patients undergoing chemotherapy frequently experience skin problems such as xerosis. The aim of this study was to verify whether a concomitant treatment with an acidic washing and an acidic emollient (both pH 5.5) can significantly improve the quality of the skin in such patients.
  
  
  METHODS
  30 adult patients on chemotherapy experiencing dry and sensitive skin were included in a controlled, monocentric, 3-week treatment trial. One forearm served as a test site, the other one remained untreated. Noninvasive biophysical measurements were performed at baseline, on days 7, 14 and 21, along with clinical evaluation of the skin symptoms.
  
  
  RESULTS
  After a 3-week treatment, a significant increase in stratum corneum hydration was recorded in the treated site (p < 0.001). Reduced transepidermal water loss values, consistent with a restored barrier function, were obtained (p < 0.001). Casual sebum levels as measured by sebumetry showed a significant increase (p < 0.03). All skin symptoms investigated revealed a considerable improvement over 3 weeks.
  
  
  CONCLUSIONS
  Controlled and regular use of a skin care system, especially an acidic one, improved skin physiology in patients undergoing chemotherapy.
authors.affiliation: Skin Physiology Laboratory, Friedrich-Schiller University, Jena, Germany. Fluhr@derma.uni-jena.de
authors.forename: J W
authors.initials: JW
authors.lastname: Fluhr
authors.forename: M
authors.initials: M
authors.lastname: Miteva
authors.forename: G
authors.initials: G
authors.lastname: Primavera
authors.forename: M
authors.initials: M
authors.lastname: Ziemer
authors.forename: P
authors.initials: P
authors.lastname: Elsner
authors.forename: E
authors.initials: E
authors.lastname: Berardesca
mesh_terms: D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004643:Emollients / Q000627:therapeutic use*; D004655:Emulsions; D004817:Epidermis / Q000187:drug effects; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D012879:Skin Physiological Phenomena; D014870:Water Loss, Insensible / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D004643:Emollients; D004655:Emulsions